Incyte

Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development, and commercialization of novel medicines. With a foundation in immunology and a legacy in JAK inhibition, we are working to address significant unmet needs with products for immune-mediated skin conditions. As a company deeply committed to the dermatology community, Incyte continues to relentlessly pursue scientific advancements to improve the lives of patients. We are excited about our dermatology portfolio and look forward to collaborating with you to make a transformative impact on the treatment of skin diseases. Join in the excitement about our FDA-approved treatment for mild to moderate atopic dermatitis and nonsegmental vitiligo. To learn more, visit ADtreatment.com or TreatVitiligoToday.com.